Skip to main content
FinSpry Logo
FinSpry
STOK logo
STOK
(NASDAQ)
Stoke Therapeutics, Inc.
$31.93-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Stoke Therapeutics (STOK) Stock Price & Financial Analysis

Stoke Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$31.60 - $33.09
52-Week High$40.22
52-Week Low$12.86
Open$31.99
Volume690.89K
Average Volume (3M)952.87K
Market Cap2.01B
Shares Outstanding63.06M
Price to Sales (P/S)62.77
Price to Book (P/B)5.10
EV/EBITDA-10.57
Revenue (TTM)32.08M
Net Income (TTM)-169.77M
Free Cash Flow (TTM)-147.69M
EPS (TTM)$-2.85
Profit Margin-529.20%
Operating Margin-577.46%
Return on Equity (ROE)-42.99%
Debt to Equity0.01
50-Day MA$30.40
200-Day MA$31.59
52-Week Change142.44%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Stoke Therapeutics

What is the current stock price for STOK?

As of the latest trading session, STOK stock trades at $31.93. The 52-week range is $12.86–$40.22, with a day range of $31.60–$33.09.

What is the P/E ratio for STOK?

The P/E ratio (Price-to-Earnings) for STOK is shown in the Key Statistics section. This valuation metric helps compare Stoke Therapeutics, Inc. to industry peers.

Does STOK pay dividends?

Stoke Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for STOK?

Based on 4 analysts, the consensus for STOK is Buy.

What is the market cap of STOK?

Stoke Therapeutics's market capitalization is $2.01B, classifying it as a mid-cap company. Stoke Therapeutics operates in the Healthcare sector within the Biotechnology industry.